BioConsortia Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series G
- Latest Deal Amount
-
$15M
- Investors
-
3
BioConsortia General Information
Description
Developer of microbial-based agricultural technologies designed to improve crop performance and sustainability. The company utilizes advanced gene discovery, trait mapping, and microbial selection techniques to develop products that enhance nitrogen fixation, bio-pesticide activity, and plant growth under stress, enabling farmers to increase yield, reduce chemical inputs and support soil health through targeted microbial solutions integrated into existing agricultural practices.
Contact Information
Website
www.bioconsortia.comCorporate Office
- 279 Cousteau Place
- Suite 100
- Davis, CA 95618
- United States
Corporate Office
- 279 Cousteau Place
- Suite 100
- Davis, CA 95618
- United States
BioConsortia Timeline
BioConsortia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series G) | 09-Oct-2026 | $15M | Completed | Generating Revenue | ||
| 11. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 04-Jun-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series F) | 20-Apr-2023 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 28-Apr-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series E) | 26-Mar-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 13-Mar-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 26-Oct-2016 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Jan-2016 | $4M | $23M | Completed | Generating Revenue | |
| 3. Early Stage VC (Series B) | 07-Apr-2014 | $15M | $19M | Completed | Generating Revenue |
BioConsortia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series G | ||||||||
| Series H | ||||||||
| Series F-2 | ||||||||
| Series F-1 | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 1,111,111 | $0.000100 | 8% | $1.8 | $1.8 | 1x | $1.8 | 1.65% |
| Series A | 1,666,667 | $0.000100 | 8% | $1.2 | $1.2 | 1x | $1.2 | 2.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BioConsortia Comparisons
Industry
Financing
Details
BioConsortia Competitors (15)
One of BioConsortia’s 15 competitors is Vestaron, a Venture Capital-Backed company based in Durham, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vestaron | Venture Capital-Backed | Durham, NC | ||||
| BioWorks (Agricultural Chemicals) | Private Equity-Backed | Victor, NY | ||||
| Sumitomo Biorational Company | Accelerator/Incubator Backed | Libertyville, IL | ||||
| American Vanguard | Corporation | Newport Beach, CA | ||||
| Syngenta | Formerly Accelerator/Incubator backed | Basel, Switzerland |
BioConsortia Patents
BioConsortia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026128393-A2 | Intergeneric diazotrophic microorganisms for use in agriculture | Pending | 10-Dec-2024 | ||
| WO-2026128393-A3 | Intergeneric diazotrophic microorganisms for use in agriculture | Pending | 10-Dec-2024 | ||
| WO-2025244817-A1 | Agriculturally beneficial microbes, microbial compositions, and consortia | Pending | 24-May-2024 | ||
| WO-2025188506-A1 | Novel genome-edited nitrogen fixing bacteria | Pending | 05-Mar-2024 | ||
| WO-2025188506-A8 | Novel genome-edited nitrogen fixing bacteria | Pending | 05-Mar-2024 | C12N15/74 |
BioConsortia Signals
BioConsortia Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Outset Ventures | Venture Capital | Minority | ||
| Otter Capital | PE/Buyout | Minority |
BioConsortia FAQs
-
When was BioConsortia founded?
BioConsortia was founded in 2014.
-
Where is BioConsortia headquartered?
BioConsortia is headquartered in Davis, CA.
-
What is the size of BioConsortia?
BioConsortia has 50 total employees.
-
What industry is BioConsortia in?
BioConsortia’s primary industry is Agricultural Chemicals.
-
Is BioConsortia a private or public company?
BioConsortia is a Private company.
-
What is the current valuation of BioConsortia?
The current valuation of BioConsortia is .
-
What is BioConsortia’s current revenue?
The current revenue for BioConsortia is .
-
How much funding has BioConsortia raised over time?
BioConsortia has raised $79M.
-
Who are BioConsortia’s investors?
Plug and Play, Outset Ventures, and Otter Capital have invested in BioConsortia.
-
Who are BioConsortia’s competitors?
Vestaron, BioWorks (Agricultural Chemicals), Sumitomo Biorational Company, American Vanguard, and Syngenta are some of the 15 competitors of BioConsortia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process